Shares of Rigel Pharmaceuticals (RIGL) have gained 24.6% over the past four weeks to close the last trading session at $21.65, but there could still be a solid upside left in the stock if short-term ...

RIGL.

The first patient has been enrolled in a Phase 1 trial by the NHLBI that's evaluating fostamatinib as a treatment for sickle ...

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Get Free Report) was the target of a significant decrease in short interest in the month of January. As of January 15th, there was short interest totalling ...

Ironwood Pharmaceuticals, Inc. IRWD announced that it has initiated the rolling new drug application (“NDA”) submission for ...

After hours: January 31 at 5:30:46 PM EST Loading Chart for RIGL ...

Based on 5 Wall Street analysts offering 12 month price targets forRigel Pharmaceuticals Inc - Dist in the last 3 months.

Evercore ISI analyst Liisa Bayko maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) on January 31 and set a price target of $515.00. The company’s shares closed last ...

Vertex Pharmaceuticals (VRTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Terence Flynn from Morgan Stanley maintained a Hold rating ...

President Trump on Friday vowed to impose sweeping tariffs on semiconductor chips, pharmaceuticals, steel and aluminum and oil and gas. “We’ll be doing pharmaceuticals. Importantly in drugs ...